Literature DB >> 31128602

Elderly sarcoidosis: A comparative study from a 42-year single-centre experience.

Manuel Rubio-Rivas1, Xavier Corbella2, Juan Mañá3.   

Abstract

OBJECTIVES: To describe the clinical features and outcomes in elderly patients with sarcoidosis and to compare them with younger patients.
MATERIAL AND METHODS: Retrospective study of a large cohort of 668 consecutive patients with sarcoidosis prospectively collected during 42 years at the Bellvitge University Hospital, a tertiary care single-centre in Barcelona, Spain. Elderly sarcoidosis was defined as sarcoidosis diagnosed in patients ≥65 years-old.
RESULTS: Elderly sarcoidosis was diagnosed in 47 (7%) patients. In younger patients, Löfgren's syndrome was the predominant mode of onset (8.5% vs. 42.2%, p < 0.001). At diagnosis, elderly patients more frequently demonstrated radiographic stage III and IV sarcoidosis (21.3% vs. 7.6%, p = 0.001), isolated extrapulmonary involvement (21.3% vs. 8.2%, p = 0.003), subcutaneous nodules (17% vs. 3.4%, p < 0.001) and intraabdominal/retroperitoneal lymph nodes (23.4% vs. 9.5%, p = 0.003). Furthermore, patients with elderly sarcoidosis achieved remission (spontaneous and under treatment) less frequently during the follow-up period (14 patients, 35% vs. 305 patients, 53%, p = 0.027) and had a higher incidence of pulmonary fibrosis (15% vs. 6.1%, p = 0.029). Death related to sarcoidosis was more prevalent in elderly patients (6.4% vs. 1.3%, p = 0.036).
CONCLUSIONS: Sarcoidosis in elderly patients requires a high index of suspicion. Aged pulmonary sarcoidosis patients presented with more severe disease at presentation and worse outcomes compared to younger patients. Isolated extrapulmonary involvement at diagnosis and certain particular extrapulmonary organ involvement were more frequent in elderly sarcoidosis. Remission was less frequent in elderly sarcoidosis.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Elderly; Prognosis; Sarcoidosis

Mesh:

Year:  2019        PMID: 31128602     DOI: 10.1016/j.rmed.2019.03.013

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  4 in total

1.  Subpopulations of cells from bronchoalveolar lavage can predict prognosis in sarcoidosis.

Authors:  Pernilla Darlington; Susanna Kullberg; Anders Eklund; Johan Grunewald
Journal:  Eur Respir J       Date:  2020-01-30       Impact factor: 16.671

2.  Understanding Predictors of Response to Repository Corticotropin Injection Treatment Among Patients With Advanced Symptomatic Sarcoidosis.

Authors:  Jas Bindra; Ishveen Chopra; Kyle Hayes; John Niewoehner; Mary P Panaccio; George J Wan
Journal:  J Health Econ Outcomes Res       Date:  2022-04-20

Review 3.  Sarcoidosis with musculoskeletal manifestations: systematic review of non-pharmacological and pharmacological treatments.

Authors:  Geir Smedslund; Annie Martina Kotar; Till Uhlig
Journal:  Rheumatol Int       Date:  2022-08-09       Impact factor: 3.580

4.  Elderly Onset Sarcoidosis: A Case Report.

Authors:  Lintu Ramachandran; Saagar Pamulapati; Aisha Barlas; Ammar Aqeel
Journal:  Cureus       Date:  2021-12-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.